Denver HIV Risk Score

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
hiv risk assessment
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Very Low Risk-14–19
  • Low Risk20–29
  • Moderate Risk30–39
  • High Risk40–49
Direct Clinical Answer

The Denver HIV Risk Score calculates predicting probability of undiagnosed HIV infection in patients aged 13 and older using demographic and behavioral risk factors. Key inputs include age group. Scores guide administering empiric broad-spectrum antimicrobial regimens, infectious source control, and isolation protocols. Routine clinical application promotes standardized evidence-based patient management.

Clinical Guidelines & Evidence

Predicts probability of undiagnosed HIV infection in patients aged 13 and older using demographic and behavioral risk factors.

Clinical Indication

The Denver HIV Risk Score is indicated for bedside clinical practice to support Predicts probability of undiagnosed HIV infection in patients aged 13 and older using demographic and behavioral risk factors.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with suspected sepsis, meningitis, pneumonia, COVID-19, opportunistic infections, or fever of unknown origin. Clinical application is indicated across Infectious disease services, septic shock bays, febrile illness clinics, and isolation units.

Limitations & Contraindications

Timely administration of empiric antibiotic therapy in suspected septic shock must never be delayed for score tabulation.

Clinical Pearls & Action Plan

Blood and site-specific microbiological cultures should be secured prior to administering broad-spectrum antimicrobials.

Formula & Variables:

Denver HIV Risk Score = Age Points + Gender Points + Sexual Practice Points + Injection Drug Use Points + Past HIV Testing Points + Race/Ethnicity Points (optional)

Input Parameters

NameTypeRequiredDescription
age_groupstringYesPatient age group with variable point assignments
genderstringYesPatient gender
sexual_practicesstringYesSexual behavior risk factors
injection_drug_usestringYesHistory of injection drug use
past_hiv_testingstringYesHistory of previous HIV testing
race_ethnicitystringNoRace/ethnicity (optional parameter for additional risk stratification)

Score Interpretation & Guidance

RangeStageDescription
-14–19Very Low RiskVery low probability of undiagnosed HIV infection
20–29Low RiskLow probability of undiagnosed HIV infection
30–39Moderate RiskModerate probability of undiagnosed HIV infection
40–49High RiskHigh probability of undiagnosed HIV infection
50–81Very High RiskVery high probability of undiagnosed HIV infection

Evidence-Based References (EBM)

  • Haukoos JS, Hopkins E, Conroy AA, et al. Derivation and validation of the Denver Human Immunodeficiency Virus (HIV) risk score for targeted HIV screening. Am J Epidemiol. 2012;175(8):838-846. doi: 10.1093/aje/kwr389.DOI: 10.1093/aje/kwr389
  • Hsieh YH, Jung JJ, Shahan JB, et al. Validation of an abbreviated version of the Denver HIV risk score for prediction of HIV infection in an urban emergency department. Acad Emerg Med. 2014;21(7):757-767. doi: 10.1111/acem.12413.DOI: 10.1111/acem.12413
  • Haukoos JS, Lyons MS, Lindsell CJ, et al. Derivation and validation of the Denver Human Immunodeficiency Virus risk score for targeted HIV screening in emergency departments. Am J Epidemiol. 2012;175(8):838-846. doi: 10.1093/aje/kwr389.DOI: 10.1093/aje/kwr389
  • Centers for Disease Control and Prevention. Screening for HIV infection: US Preventive Services Task Force recommendation statement. JAMA. 2019;321(23):2326-2336. doi: 10.1001/jama.2019.6587.DOI: 10.1001/jama.2019.6587

Related calculators